286 related articles for article (PubMed ID: 8222122)
1. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators.
Konstam MA; Kronenberg MW; Rousseau MF; Udelson JE; Melin J; Stewart D; Dolan N; Edens TR; Ahn S; Kinan D
Circulation; 1993 Nov; 88(5 Pt 1):2277-83. PubMed ID: 8222122
[TBL] [Abstract][Full Text] [Related]
2. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators.
Konstam MA; Rousseau MF; Kronenberg MW; Udelson JE; Melin J; Stewart D; Dolan N; Edens TR; Ahn S; Kinan D
Circulation; 1992 Aug; 86(2):431-8. PubMed ID: 1638712
[TBL] [Abstract][Full Text] [Related]
3. Effects of long-term enalapril therapy on left ventricular diastolic properties in patients with depressed ejection fraction. SOLVD Investigators.
Pouleur H; Rousseau MF; van Eyll C; Stoleru L; Hayashida W; Udelson JA; Dolan N; Kinan D; Gallagher P; Ahn S
Circulation; 1993 Aug; 88(2):481-91. PubMed ID: 8101772
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of preload reserve as a determinant of clinical status in patients with left ventricular systolic dysfunction. The SOLVD Investigators.
Konstam MA; Kronenberg MW; Udelson JE; Kinan D; Metherall J; Dolan N; Edens T; Howe D; Kilcoyne L; Benedict C
Am J Cardiol; 1992 Jun; 69(19):1591-5. PubMed ID: 1598875
[TBL] [Abstract][Full Text] [Related]
5. Acute and long-term effects of the angiotensin-converting enzyme inhibitor, enalapril, on adrenergic activity and sensitivity during exercise in patients with left ventricular systolic dysfunction.
Patten RD; Kronenberg MW; Benedict CR; Udelson JE; Kinan D; Stewart D; Yusuf S; Smith JJ; Kilcoyne L; Dolan N; Edens TR; Metherall J; Konstam MA
Am Heart J; 1997 Jul; 134(1):37-43. PubMed ID: 9266781
[TBL] [Abstract][Full Text] [Related]
6. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy.
Greenberg B; Quinones MA; Koilpillai C; Limacher M; Shindler D; Benedict C; Shelton B
Circulation; 1995 May; 91(10):2573-81. PubMed ID: 7743619
[TBL] [Abstract][Full Text] [Related]
7. Benefit of converting enzyme inhibition on left ventricular volumes and ejection fraction in patients receiving beta-blockade after myocardial infarction. CONSENSUS II multiecho study group.
Bonarjee VV; Carstensen S; Caidahl K; Nilsen DW; Edner M; Lindvall K; Snapinn SM; Berning J
Am Heart J; 1996 Jul; 132(1 Pt 1):71-7. PubMed ID: 8701878
[TBL] [Abstract][Full Text] [Related]
8. Radionuclide monitoring of cardiac adaptations to volume loading in patients with dilated cardiomyopathy and mild heart failure. Effects of angiotensin-converting enzyme inhibition.
Volpe M; Rao MA; Cuocolo A; Russo R; Nappi A; Mele AF; Enea I; Trimarco B; Condorelli M
Circulation; 1995 Nov; 92(9):2511-8. PubMed ID: 7586352
[TBL] [Abstract][Full Text] [Related]
9. Comparison of enalapril versus captopril on left ventricular function and survival three months after acute myocardial infarction (the "PRACTICAL" study).
Foy SG; Crozier IG; Turner JG; Richards AM; Frampton CM; Nicholls MG; Ikram H
Am J Cardiol; 1994 Jun; 73(16):1180-6. PubMed ID: 8203335
[TBL] [Abstract][Full Text] [Related]
10. Trends in Kidney Function Outcomes Following RAAS Inhibition in Patients With Heart Failure With Reduced Ejection Fraction.
McCallum W; Tighiouart H; Ku E; Salem D; Sarnak MJ
Am J Kidney Dis; 2020 Jan; 75(1):21-29. PubMed ID: 31303349
[TBL] [Abstract][Full Text] [Related]
11. Regional remodeling and nonuniform changes in diastolic function in patients with left ventricular dysfunction: modification by long-term enalapril treatment. The SOLVD Investigators.
Hayashida W; Van Eyll C; Rousseau MF; Pouleur H
J Am Coll Cardiol; 1993 Nov; 22(5):1403-10. PubMed ID: 8227798
[TBL] [Abstract][Full Text] [Related]
12. Contractile state is the major determinant of functional outcome in patients with left ventricular dysfunction treated with enalapril.
Mirsky I; Aoyagi T; Ihara T; van Eyll C; Rousseau MF; Pouleur H
Eur Heart J; 1995 Jun; 16(6):808-17. PubMed ID: 7588925
[TBL] [Abstract][Full Text] [Related]
13. Changes in ventricular volume, wall thickness and wall stress during progression of left ventricular dysfunction. The SOLVD Investigators.
Pouleur HG; Konstam MA; Udelson JE; Rousseau MF
J Am Coll Cardiol; 1993 Oct; 22(4 Suppl A):43A-48A. PubMed ID: 8376696
[TBL] [Abstract][Full Text] [Related]
14. An angiotensin-converting enzyme inhibitor improves left ventricular systolic and diastolic function in transfusion-dependent patients with beta-thalassemia major.
Karvounis HI; Zaglavara TA; Parharidis GE; Nouskas IG; Hassapopoulou EP; Gemitzis KD; Louridas GE
Am Heart J; 2001 Feb; 141(2):281. PubMed ID: 11174351
[TBL] [Abstract][Full Text] [Related]
15. Early treatment with low-dose enalapril after acute myocardial infarction: an equilibrium radionuclide angiographic study. Enalapril despues del Infarto (EDI) Trial Investigators.
Bazzino O; Navarro Estrada JL; Sosa Liprandi A; Presti C; Masoli O; Santopinto J; Ahuad A; Amuchástegui M; Méndez R
J Nucl Cardiol; 1997; 4(2 Pt 1):133-9. PubMed ID: 9115065
[TBL] [Abstract][Full Text] [Related]
16. Effects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction.
Sabbah HN; Shimoyama H; Kono T; Gupta RC; Sharov VG; Scicli G; Levine TB; Goldstein S
Circulation; 1994 Jun; 89(6):2852-9. PubMed ID: 8205701
[TBL] [Abstract][Full Text] [Related]
17. Effect and safety of treatment with ACE-inhibitor Enalapril and β-blocker metoprolol on the onset of left ventricular dysfunction in Duchenne muscular dystrophy - a randomized, double-blind, placebo-controlled trial.
Dittrich S; Graf E; Trollmann R; Neudorf U; Schara U; Heilmann A; von der Hagen M; Stiller B; Kirschner J; Pozza RD; Müller-Felber W; Weiss K; von Au K; Khalil M; Motz R; Korenke C; Lange M; Wilichowski E; Pattathu J; Ebinger F; Wiechmann N; Schröder R;
Orphanet J Rare Dis; 2019 May; 14(1):105. PubMed ID: 31077250
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both.
Yan RT; White M; Yan AT; Yusuf S; Rouleau JL; Maggioni AP; Hall C; Latini R; Afzal R; Floras J; Masson S; McKelvie RS;
Am J Cardiol; 2005 Sep; 96(5):698-704. PubMed ID: 16125499
[TBL] [Abstract][Full Text] [Related]
19. Effects of nisoldipine and/or enalapril on left ventricular function and exercise capacity in patients with recent anterior myocardial infarction and mild cardiac dysfunction.
Romano M; Cardei S; de Arcangelis E; Monteforte I; Capaldo M; Muto P; Marchegiano R; Kilama MO; Condorelli M
Am Heart J; 1997 Mar; 133(3):268-72. PubMed ID: 9060793
[TBL] [Abstract][Full Text] [Related]
20. Effect of comorbidities on outcomes and angiotensin converting enzyme inhibitor effects in patients with predominantly left ventricular dysfunction and heart failure.
Böhm M; Pogue J; Kindermann I; Pöss J; Koon T; Yusuf S
Eur J Heart Fail; 2014 Mar; 16(3):325-33. PubMed ID: 24464788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
